Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals

Author:

Duenas-Gonzalez Alfonso12,Gonzalez-Fierro Aurora2,Bornstein-Quevedo Leticia3,Gutierrez-Delgado Francisco4,Kast Richard E.5,Chavez-Blanco Alma2,Dominguez-Gomez Guadalupe2,Candelaria Myrna6,Romo-Pérez Adriana7,Correa-Basurto Jose8,Lizano Marcela12,Perez-de la Cruz Veronica9,Robles-Bañuelos Benjamin2,Nuñez-Corona David2,Martinez-Perez Erandi2,Verastegui Emma10

Affiliation:

1. Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas UNAM, Mexico City, Mexico

2. Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico

3. Immunohistochemistry and Molecular Biology Laboratory, InmunoQ, Mexico City, Mexico

4. Centro de Estudios y Prevención del Cancer Tuxtla Gutiérrez, Chiapas, México; Latin American School of Oncology (ELO), México City, Mexico

5. Head of Faculty, Brain Study, IIAIG Study Center, Burlington, VT, USA

6. Departamento de Hematología, Instituto Nacional de Cancerología, Mexico City, Mexico

7. Instituto de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico

8. Laboratorio de Diseño y Desarrollo de Nuevos Fármacos e Innovación Biotecnológica, SEPI-ESM, Instituto Politécnico Nacional, México, Mexico City, Mexico

9. Neurobiochemistry and Behavior Laboratory, National Institute of Neurology and Neurosurgery “Manuel Velasco Suárez”, Mexico City, Mexico

10. Departamento de Cuidados Paliativos, Division de Cirugia, Instituto Nacional de Cancerologia, Mexico City, Mexico

Publisher

Informa UK Limited

Reference96 articles.

1. Paradigm errors in the old biomedical science

2. Why Is Modern Medicine Stuck in a Rut?

3. Two views of cancer medicines: Imagery versus evidence

4. Conflicts of interest and expertise of independent commenters in news stories about medical research

5. Financial conflict of interest and anti-cancer drugs: why the NTVG’s stance to exclude pharma-advertisement is of importance;Schnog J-J;Ned Tijdschr Geneeskd,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3